1. Japan Stocks

  2. •

    Communication Services

  3. •

    Advertising Agencies
GMO TECH Holdings, Inc.

GMO TECH Holdings, Inc.

415A.T
GMO TECH Holdings, Inc.JP flagTokyo Stock Exchange
5,030.00
JPY
+85.00
- -
7.94BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2,369.92
3,012.39
3,126.39
2,676.56
2,656.08
2,634.77
2,456.44
2,541.71
4,007.54
5,142.32
5,896.45
6,436.56
5,686.28
6,660.73
Basic EPS, GAAP
114.62
156.78
200.04
7.03
44.93
-165.84
129.63
13.25
-271.44
-278.04
381.72
626.97
1,264.08
499.95
Free Cash Flow per Basic Share
126.98
116.15
248.82
-83.13
192.66
-106.73
4.2
-106.51
-208.29
-152.69
210.18
259.6
30.39
- -
Dividend per Share
36.55
51.28
51.85
71.78
0.06
30.36
0.12
67.9
0.05
- -
- -
199.62
280.08
- -
Book Value per Share
192.35
773.9
921.35
797.4
843.93
651.47
783.86
727.42
455.23
370.41
757.29
1,150.61
2,532.4
907.83
Tangible Book Value per Share
187.73
765.19
911.97
796.88
843.8
650.39
782.53
598.81
127.24
344.96
617.3
921.62
2,279.03
742.18
Basic Weighted Avg Shares
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Sales/Revenue/Turnover
2,370
3,030
3,439
2,867
2,819
2,796
2,607
2,697
4,252
5,456
6,256
6,868
6,923
7,101
Operating Margin (%)
16.61
17.64
20.5
13.32
3.71
-3.42
0.86
0.62
-6.07
4.14
9.05
13.09
7.51
10.97
Depreciation Expense
2
5
8
14
3
19
5
11
55
48
15
36
76
- -
Net Income, GAAP
115
158
220
8
48
-176
138
14
-288
-295
405
669
1,539
533
Effective Tax Rate (%)
38.04
39.61
38.02
52.63
45.17
- -
18.67
25.66
- -
- -
27.94
29.43
5
33.87
Profit Margin (%)
4.84
5.2
6.4
0.26
1.69
-6.29
5.28
0.52
-6.77
-5.41
6.47
9.74
22.23
7.51
Working Capital
182
812
944
708
756
561
687
528
97
556
735
1,035
2,993
871
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
90
280
210
140
90
175
Total Equity
212
851
1,013
846
896
691
832
772
483
393
806
1,221
3,998
970
Return on Invested Capital (%)
- -
51.54
40.89
17.83
6.23
- -
2.36
1.52
- -
- -
41.16
44.93
17.17
43.55
Return on Capital (%)
- -
29.67
23.6
0.81
5.47
- -
18.06
1.75
- -
- -
44.52
53.33
55.08
49.34
Return on Common Equity (%)
- -
29.67
23.6
0.81
5.47
-22.18
18.06
1.75
-45.9
-67.35
67.56
66.01
58.98
66.38

Capital Structure

FRC

•

in mil. unless spec.
Dec'23
Mar'24
Jun'24
ST Debt
70
70
70
LT Borrowings
210
192
175
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1
1
1
Market Capitalization
4,332
6,881
13,356

Working Capital

FRC

•

in mil. unless spec.
Dec'23
Mar'24
Jun'24
Total Current Assets
2,463
2,181
2,254
Cash, Cash Equivalents & STI
1,279
898
1,149
Accounts Receivable, Net
1,029
1,110
949
Inventories
- -
- -
- -
Total Current Liabilities
1,728
1,446
1,383
Payables & Accruals
- -
- -
- -
ST Debt
70
70
70
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
30.76%
65.59%
227.44%
Free Cash Flow
-358.71%
-46.24%
-86.64%
Net Income, GAAP
-248.88%
-437.63%
130.04%
Sales/Revenue/Turnover
8.88%
22.25%
0.8%
Total Cash Common Dividend
- -
- -
60.09%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,874
1,820
- -
- -
6,868
2025
- -
- -
- -
- -
6,923
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
181.97
- -
- -
- -
626.97
2025
- -
- -
- -
- -
1,264.08
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
199.62
2025
- -
- -
- -
- -
280.08
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Akito Suzuki
Full Time Employees
414
Sector
Communication Services
Industry
Advertising Agencies
Address
26-1 Sakuragaokacho Tokyo TY Japan
IPO Date
Dec 11, 2014
Website
hd.gmotech.jp
Similar Companies
Ecom Products Group Corporation (EPGC)
SpaceandPeople plc (SAL.L)
GBX International Group Inc. (GBXI)
Innovatus Entertainment Networ (INNOVATUS.BO)
Hopscotch Global PR Group (HOP.PA)
Digital Media Solutions, Inc. (DMSL)
Business
GMO TECH Holdings, Inc. engages in the design, development, and sale of genetic engineering, biotechnology, and related technology tools and services. The company focuses on high-throughput molecular biology platforms, genome editing technologies, and analytical software that enable researchers and institutions to perform genetic modification, construct libraries, and analyze genomic data. Its product suite includes gene editing reagents, genomic engineering kits, cell line generation tools, and associated consumables; software and analytics platforms for design, simulation, data management, and result interpretation; and professional services such as project design, optimization support, and training. Latest major changes and strategic developments include recent partnerships and strategic alliances with research institutions and biotechnology firms to co-develop and commercialize next-generation genome editing capabilities; funding rounds or acquisitions that expand technology breadth and geographic reach, including investments in platform integration and analytics capabilities; new product launches and service offerings that broaden application areas in synthetic biology, functional genomics, and precision medicine; organizational restructuring or rebranding to align corporate identity with expanded product scope; and operational enhancements aimed at scaling manufacturing, expanding regional sales coverage, and accelerating go-to-market activities over the past 1–2 years. Additional context: operates in the biotechnology and life sciences equipment and services segments; targets academic, pharmaceutical, and contract research organizations; geographic operations span Japan and international markets; founded in 200X with headquarters in Japan; maintains subsidiaries or parent relationships as part of a broader corporate group structure.